321
Participants
Start Date
October 10, 2018
Primary Completion Date
June 30, 2026
Study Completion Date
December 31, 2026
INBRX-109
Tetravalent DR5 Agonist Antibody
Carboplatin
Chemotherapy
Cisplatin
Chemotherapy
Pemetrexed
Chemotherapy
5-fluorouracil
Chemotherapy
Irinotecan
Chemotherapy
Temozolomide
Chemotherapy
RECRUITING
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
RECRUITING
La Fondazione e l'Istituto di Candiolo, Candiolo
RECRUITING
Children's Hospital of Philadelphia- Center for Childhood Cancer Research, Philadelphia
RECRUITING
University of Pennsylvania Abramson Cancer Center, Philadelphia
NOT_YET_RECRUITING
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
NOT_YET_RECRUITING
Center for Cancer Research at NCI, Bethesda
RECRUITING
NEXT Oncology - Virginia, Fairfax
NOT_YET_RECRUITING
University of Virginia, Charlottesville
RECRUITING
Hospital Clinico San Carlos, Madrid
RECRUITING
Emory University - Winship Cancer Institute, Atlanta
RECRUITING
Vanderbilt University School of Medicine, Nashville
RECRUITING
Cleveland Clinic, Cleveland
RECRUITING
University of Michigan, Ann Arbor
RECRUITING
START Midwest Michigan, PC, Grand Rapids
COMPLETED
The University of Chicago, Chicago
RECRUITING
Centre Leon Berard, Lyon
RECRUITING
UT MD Anderson Cancer Center, Houston
COMPLETED
NEXT Oncology, San Antonio
RECRUITING
University of Colorado Hospital, Aurora
COMPLETED
HonorHealth Research Institute, Scottsdale
RECRUITING
Valkyrie Clinical Trials, Los Angeles
RECRUITING
Precision NextGen Oncology and Research, Beverly Hills
RECRUITING
Sarcoma Oncology Center, Santa Monica
RECRUITING
City of Hope, Duarte
RECRUITING
University of California, San Diego (UCSD) - Moores Cancer Center, San Diego
RECRUITING
University of California, San Francisco (UCSF), San Francisco
RECRUITING
Gustave Roussy, Villejuif
RECRUITING
Oregon Health & Science University, Portland
NOT_YET_RECRUITING
Hospital Universitario Vall d'Hebron, Barcelona
RECRUITING
Hospital de la Santa Creu i Sant Pau, Barcelona
NOT_YET_RECRUITING
Great North Children's Hospital, London
RECRUITING
University College London Hospital, London
NOT_YET_RECRUITING
The Royal Marsden NHS Foundation Trust, London
NOT_YET_RECRUITING
Royal Manchester Children's Hospital, Manchester
Lead Sponsor
Inhibrx Biosciences, Inc
INDUSTRY